B2B buyers sourcing Epitalon / Epithalon should confirm five items before comparing supplier quotes: spelling and naming convention, AEDG tetrapeptide sequence reference, CAS number, analytical documentation package, and whether the supplier is quoting bulk powder or lyophilized vial format. Without these details, a low USD/g or USD/vial price may reflect a naming mismatch, an incomplete documentation package, or a project scope that does not match the buyer’s requirements.
This guide is written for distributors, private label teams, OEM coordinators, and formulation consultants preparing a structured RFQ for Epitalon / Epithalon. It covers naming clarification, specification review, documentation requirements, format selection, MOQ and lead time considerations, red flags to watch for, and how WUMO reviews a sourcing project before issuing a formal quotation. No dosing, injection, reconstitution, anti-aging, longevity, or end-use guidance is included. This is a procurement reference, not a product description.
What Should Buyers Confirm First When Sourcing Epitalon / Epithalon?
Buyers should confirm that the supplier’s Epitalon / Epithalon specification matches the expected AEDG tetrapeptide sequence, CAS reference, molecular formula, molecular weight, and batch documentation before requesting a price. A spelling variant or product name alone is not sufficient for supplier qualification.
Epitalon and Epithalon are two spellings encountered for the same tetrapeptide in B2B sourcing contexts. The sequence commonly referenced is Ala-Glu-Asp-Gly (AEDG). The CAS number commonly referenced is 307297-39-8. The molecular formula commonly referenced is C₁₄H₂₂N₄O₉, with a molecular weight of approximately 390.35 g/mol. All of these fields should be confirmed against the supplier’s specification sheet — not assumed from a catalog title.
This confirmation matters at the inquiry stage. A supplier that cannot provide a specification sheet listing sequence, CAS, purity method, and batch reference before issuing a price has not completed basic documentation preparation for B2B procurement. Buyers who proceed without these confirmations frequently find themselves comparing quotes that reference different products, different documentation scopes, or different format assumptions — a comparison that cannot be resolved after quotation without restarting the qualification process.
Why Do Epitalon / Epithalon Sourcing Projects Stall?
Epitalon / Epithalon sourcing projects most commonly stall when buyers compare prices before confirming spelling consistency, sequence, CAS reference, batch-specific documentation, format, fill amount, MOQ basis, and lead time scope. Similar naming does not guarantee equivalent supplier specifications, and a price comparison built on unconfirmed assumptions cannot support a reliable procurement decision.
The pattern is familiar to buyers who have sourced across multiple peptide suppliers. A buyer sends a short inquiry using one spelling of the product name. The supplier responds using a different spelling and issues a price based on their catalog standard — which may have a different purity threshold, an undisclosed salt form, or no LC-MS data attached. A second supplier responds with a lyophilized vial price but does not state the fill amount. A third provides a COA without a batch number. The buyer has three prices and no basis for comparison.
Common stall points to address before any RFQ is issued:
- Supplier uses Epitalon, Epithalon, or AEDG inconsistently across documents
- Product name quoted without sequence confirmation from a specification sheet
- CAS reference missing or inconsistent across COA, label, and specification sheet
- COA provided without a batch number — no lot traceability
- HPLC purity figure stated without a chromatogram or method details
- LC-MS not available, or not linked to the same batch as the COA
- USD/vial quote issued without a stated fill amount per vial
- MOQ stated as a single number without clarifying stock vs production basis
- Lead time given without separating production, QC, documentation, and dispatch
- Documentation offered only after payment — no pre-order review window
- Supplier issues an automatic quote without reviewing the buyer’s specification
What Naming and Sequence Issues Should Buyers Clarify?
The key naming issue for Epitalon / Epithalon is that buyers may encounter both spellings — and sometimes the shorthand AEDG — used inconsistently across supplier catalogs, COAs, and specification sheets. Buyers should confirm that all naming variations in a supplier’s documents point to the same tetrapeptide sequence and the same CAS reference before proceeding to quotation.
Naming Variation Checklist
- Confirm whether the supplier uses Epitalon, Epithalon, or both
- Confirm whether AEDG appears in the specification sheet as the sequence identifier
- Confirm that the sequence Ala-Glu-Asp-Gly is listed explicitly
- Confirm the CAS number 307297-39-8 in the specification sheet
- Confirm molecular formula and molecular weight against the specification sheet
- Confirm whether a salt form or counterion is relevant and disclosed
- Confirm that the product name on the label, COA, packing list, and specification sheet is consistent
- Confirm that the batch identity is traceable across all documents
Why Naming Clarity Matters in Procurement
Naming inconsistency between documents is not merely an administrative issue — it creates a document mismatch risk that can affect import review, internal QC records, and reorder management. A COA that uses one spelling and a packing list that uses another will require explanation at every downstream handoff.
The RFQ should state both the buyer’s preferred product name and the sequence reference (AEDG or Ala-Glu-Asp-Gly). This gives the supplier clear instructions for how to label documents and ensures that the quotation is traceable to the correct specification. A supplier that relies on catalog title alone — without anchoring the product to a sequence and CAS reference — is not operating at the documentation standard required for structured B2B procurement.
What Specification Fields Should Every Epitalon Buyer Review?
Before issuing an RFQ for Epitalon / Epithalon, buyers should review ten core specification fields: product name and naming consistency, sequence reference, CAS number, molecular formula, molecular weight, purity method and threshold, salt form, appearance, storage condition, and shelf life. Missing any of these fields increases the risk of comparing quotes that do not reflect equivalent products.
Core Specification Fields
| Specification Field | What Buyers Should Confirm |
|---|---|
| Product name | Epitalon / Epithalon, consistently used across all supplier documents |
| Sequence | Ala-Glu-Asp-Gly / AEDG, confirmed in specification sheet |
| CAS reference | 307297-39-8, confirmed against supplier specification |
| Molecular formula | C₁₄H₂₂N₄O₉, or supplier-documented equivalent |
| Molecular weight | ~390.35 g/mol theoretical; observed mass confirmed via LC-MS where available |
| Purity | HPLC area%; buyer-defined threshold stated in RFQ |
| Salt form / counterion | Confirm whether applicable; disclose in specification sheet |
| Appearance | White to off-white lyophilized powder, or per supplier standard |
| Storage condition | Supplier-defined temperature, humidity, and light handling requirements |
| Shelf life / retest date | Lot-specific statement or supplier-standard shelf life |
Why Sequence Confirmation Matters
Epitalon / Epithalon is frequently requested in procurement by product name only, without a sequence or CAS anchor. For a short tetrapeptide, the sequence is the product — and confirming it removes any ambiguity about what is being quoted. LC-MS data, where available, supports molecular weight confirmation as an independent identity check alongside sequence reference on the specification sheet. For a four-residue peptide, LC-MS verification is straightforward and should be available from any supplier operating at a B2B documentation standard. If a supplier cannot provide LC-MS for a tetrapeptide, buyers should ask why before proceeding.
What Documents Should Buyers Request Before Comparing Epitalon / Epithalon Quotes?
Buyers should request five documents before comparing Epitalon / Epithalon supplier quotes: COA, HPLC report, LC-MS report where available, SDS, and the supplier’s specification sheet. Each document confirms a different aspect of supplier qualification and should be reviewed before a formal RFQ is issued.
Document Review Table
| Document | What It Confirms | When to Request | Why It Matters for Epitalon / Epithalon |
|---|---|---|---|
| COA | Batch identity, purity, appearance, test results | At qualification stage, before RFQ | Confirms lot-level data and traceability |
| HPLC report | Purity by chromatographic method; area% | Together with COA | Supports the purity figure with method detail |
| LC-MS report | Molecular weight confirmation and identity support | Before final supplier comparison | For a tetrapeptide, LC-MS should be straightforward to supply |
| SDS | Handling, storage, and transport classification | Before any shipment discussion | Required for freight team review and customs planning |
| Specification sheet | Supplier’s defined product standard | Before quote comparison begins | Confirms naming, sequence, CAS, and what is actually being quoted |
What Documentation Does Not Guarantee
The COA confirms lot-specific test results — it does not confirm that the product will pass import inspection in the buyer’s target market. The HPLC report confirms purity by chromatographic method — it does not confirm sequence identity. The LC-MS report supports molecular weight confirmation — it is not a regulatory filing. The SDS supports handling and transport planning — it does not confirm purity or product identity. No document in this package guarantees import clearance or regulatory approval in any jurisdiction. Buyers are responsible for evaluating the regulatory requirements applicable to their market and end-use context.
Practical requirements for each document:
- COA must be batch-specific — a generic template without a lot number is not acceptable
- HPLC report should include the chromatogram and method parameters, not just the purity figure
- LC-MS should be linked to the same batch as the COA wherever possible
- Specification sheet should be reviewed before the quotation stage, not after payment
What Red Flags Suggest an Epitalon Supplier Is Not Ready for B2B Projects?
The most serious red flags in Epitalon / Epithalon sourcing are inconsistent naming across documents, missing sequence reference in the specification sheet, COA without a batch number, purity claim without HPLC support, no explanation for missing LC-MS on a tetrapeptide, and a quotation issued before the supplier has reviewed the buyer’s specification.
Red Flag Assessment Table
| Red Flag | Why It Matters | Buyer Action |
|---|---|---|
| Supplier uses Epitalon / Epithalon inconsistently across documents | Naming mismatch may create traceability gaps | Request specification sheet with consistent naming |
| Sequence not listed in specification sheet | Product identity is unconfirmed | Request AEDG sequence confirmation in writing |
| COA has no batch number | No batch traceability; cannot link to test records | Request a batch-linked COA before proceeding |
| HPLC purity stated without chromatogram | Purity figure cannot be independently reviewed | Request full HPLC report with method details |
| LC-MS unavailable for a tetrapeptide without explanation | For a short sequence, absence needs explanation | Ask directly; evaluate the response |
| USD/vial quote issued without fill amount | Price per vial cannot be normalized for comparison | Request fill amount (mg/vial) before comparing |
| MOQ stated verbally only | No documented batch basis for project planning | Request written MOQ confirmation with basis |
| Lead time given as a single number | Timeline scope is unclear; risk of underestimate | Ask for stage-by-stage breakdown |
| Documents available only after payment | Buyer has no pre-order review window | Request representative documents at qualification stage |
| Supplier auto-quotes without specification review | Project fit and product identity are not being checked | Ask the supplier to confirm specification review |
Should Buyers Choose Bulk Powder or Lyophilized Vial Format?
Bulk powder is more appropriate when the buyer needs downstream processing flexibility, reformulation, or repackaging capability. Lyophilized vial format is more appropriate when the project requires a defined, shelf-ready unit for distribution, private label, or OEM delivery. The two formats involve different MOQ structures, lead times, documentation scopes, and specification priorities and should not be compared as equivalent options.
Format Comparison Table
| Factor | Bulk Powder | Lyophilized Vial |
|---|---|---|
| Typical buyer | Distributor, formulator, repackager | Private label, OEM, distribution-ready project |
| Quote unit | USD/g or USD/mg | USD/vial or USD/box |
| MOQ basis | Gram quantity or production batch size | Vial count, box count, or fill batch minimum |
| Key specification priority | Sequence, purity, salt form, net packaging weight | Fill amount, vial size, stopper type, label format |
| Lead time | Shorter when stock is available | Longer due to fill-and-finish scheduling |
| Documentation | COA, HPLC, LC-MS, SDS, specification sheet | Core documents plus fill batch records and packaging details |
| Custom options | Container size, packaging format, desiccant handling | Fill amount, vial configuration, label format, box count |
| Shipment planning | Storage condition, packaging type, cold chain requirements | Storage, vial packaging configuration, box format, freight planning |
Choosing Format Based on Project Type
A buyer sourcing Epitalon / Epithalon for further processing or private formulation will typically work with bulk powder, quoting in USD/g with MOQ defined by batch weight or available stock. A buyer building a lyophilized vial SKU for distribution or private label will work with vial format, where fill amount per vial, vial size, stopper configuration, and box count all need to be defined before a meaningful quotation can be issued.
For custom fill projects, the salt form must be confirmed before fill weight calculations are possible. A buyer entering a custom fill discussion for Epitalon / Epithalon without knowing the salt form will receive fill weight estimates that may be inaccurate by a margin that matters at the vial level. This is a specification gap that needs to be resolved at the RFQ stage, not after production begins.
For a detailed guide on lyophilized vial specification, fill amount, packaging, and MOQ, see Lyophilized Peptide Vial Sourcing: Fill Amount, Packaging, MOQ, and Documentation.
What Do MOQ and Lead Time Actually Mean for Epitalon / Epithalon Projects?
MOQ and lead time for Epitalon / Epithalon sourcing depend on stock status, format, batch size, documentation scope, and whether the project involves custom filling or private label packaging. Buyers should confirm both in writing before accepting a quotation — verbal or chat-based estimates carry no planning reliability.
MOQ and Lead Time Matrix
| Scenario | MOQ Basis | Lead Time Factor | Key Confirmation Needed |
|---|---|---|---|
| Bulk powder, in stock | Per gram or available lot quantity | Shorter | Confirm available stock quantity and retest date |
| Bulk powder, production required | Minimum production batch size | Longer | Confirm synthesis schedule and QC timeline |
| Standard lyophilized vial | Vial count or fill batch minimum | Moderate to long | Confirm fill schedule availability |
| Custom fill, standard label | Fill batch minimum | Long | Confirm fill amount, vial format, and batch commitment |
| Custom fill, private label | Fill batch minimum plus packaging scope | Longest | Confirm label artwork approval process and timeline |
What MOQ Actually Means
MOQ is not a single standardized figure. Depending on the supplier, it may refer to the minimum stock order at a given price, the minimum that triggers a production run, the minimum fill batch for vial format, or the minimum order value. When a supplier states an MOQ, buyers should ask directly: is this for stock orders, production batches, or custom fill batches? Each scenario has different planning implications and different lead time assumptions attached to it.
What Lead Time Actually Includes
Lead time for Epitalon / Epithalon bulk powder includes synthesis, purification, QC testing, documentation preparation, and export packing. For lyophilized vials, the same steps apply plus fill-and-finish scheduling, secondary packaging, and — for custom or private label orders — label artwork review and approval. Freight transit time from the supplier’s location to the buyer’s destination is entirely separate from production lead time and should be planned independently based on the specific shipping route and carrier.
For a broader discussion of MOQ and lead time factors across peptide formats, see Bulk Peptide Purchasing Guide: MOQ, Lead Time, and Cost Considerations.
How Should Buyers Prepare a Stronger RFQ for Epitalon / Epithalon?
A stronger Epitalon / Epithalon RFQ defines naming preference, AEDG sequence reference, CAS number, format, fill amount if vials are needed, purity threshold, required documents, MOQ range, destination, and quote unit before the supplier responds. This prevents suppliers from quoting against their own default assumptions and makes quote comparison reliable.
The most common failure in Epitalon / Epithalon RFQs is not missing information — it is leaving key fields unstated. When the buyer does not specify purity threshold, the supplier assumes a minimum. When the buyer does not specify salt form, the supplier quotes what they stock. When the buyer does not specify fill amount for vials, the USD/vial figure cannot be compared against any other quote. None of these gaps are difficult to close — they require the buyer to resolve them before sending the RFQ, not after receiving a price.
RFQ Field Checklist
| RFQ Field | Why It Matters |
|---|---|
| Product name | States the buyer’s preferred naming: Epitalon, Epithalon, or AEDG |
| Sequence reference | Confirms AEDG / Ala-Glu-Asp-Gly identity |
| CAS reference | Supports supplier document matching against 307297-39-8 |
| Format: bulk powder or lyophilized vial | Determines MOQ structure, quote unit, and lead time basis |
| Fill amount (if vials are requested) | Required to normalize USD/vial comparisons |
| Purity threshold and test method | Enables comparable quote review across suppliers |
| Required documents | Sets expectations: COA, HPLC, LC-MS, SDS, specification sheet |
| Target MOQ and acceptable range | Filters out suppliers whose minimum batch does not match project scale |
| Destination country or region | Affects SDS version, label language requirements, and freight planning |
| Project timeline | Allows supplier to confirm feasibility before quoting |
| Quote unit preference | Avoids USD/g vs USD/vial confusion in quote comparison |
For a detailed breakdown of quote unit structures across peptide projects, see Peptide Quote Units: USD/g vs Vial vs Box.
What Supplier Qualification Checkpoints Apply to Epitalon / Epithalon Projects?
A qualified Epitalon / Epithalon supplier should confirm sequence, CAS reference, naming consistency, documentation scope, MOQ basis, lead time, and batch traceability before issuing a formal quotation. A supplier that cannot define these fields during qualification is not ready for final vendor comparison.
Qualification Checkpoint List
- Supplier confirms Epitalon / Epithalon naming and AEDG sequence from a specification sheet, not from a catalog label
- Specification sheet is available before formal quotation is issued
- Batch-specific COA is available, with lot number and test date
- HPLC chromatogram supports the stated purity result, with method parameters included
- LC-MS data is available for the tetrapeptide, or the supplier provides a clear explanation of why it is not
- SDS is available at the inquiry stage, before shipment discussion begins
- Batch number links to COA, HPLC, LC-MS, and any associated test records
- MOQ is confirmed in writing with clear basis: stock quantity, production batch, or vial fill batch
- Lead time is stated with production vs stock basis, and QC and documentation stages noted separately
- Supplier reviews buyer specification before quoting — not a catalog auto-quote
- Custom fill or private label capability is confirmed in advance if the project requires it
For a full supplier evaluation framework, see Peptide Supplier Qualification Checklist.
What Does WUMO Review Before Issuing a Formal Quotation?
WUMO reviews product identity, documentation availability, MOQ feasibility, quote unit basis, and project fit before issuing a formal Epitalon / Epithalon quotation. No auto-generated quotes are issued for specification-sensitive projects. A useful quotation starts with confirmed product definition — not a catalog price.
For every Epitalon / Epithalon inquiry, WUMO’s pre-quotation review covers:
Product identity and naming alignment
WUMO confirms that the buyer’s stated product name, sequence reference, and CAS number match the available sourcing specification before any price discussion begins. If the buyer’s inquiry uses one spelling and the available documentation uses another, this is resolved before quotation — not left for the buyer to discover after receiving a price.
Documentation availability
WUMO verifies which documents are available for the relevant lot or batch: COA, HPLC, LC-MS, SDS, and specification sheet. For Epitalon / Epithalon, LC-MS availability is reviewed as a standard checkpoint given the sequence-confirmation requirement. If documentation gaps exist, they are communicated before quotation.
MOQ and quantity feasibility
WUMO reviews whether the buyer’s target quantity aligns with minimum batch requirements for the requested format. For vial-format projects, this includes confirming fill amount, vial configuration, and whether the requested configuration falls within available fill capacity.
Quote unit alignment
Before issuing a formal quotation, WUMO confirms the buyer’s preferred quote unit: USD/g, USD/vial, or USD/box. Mismatched quote units across a supplier comparison set produce unreliable results. Aligning on this at the inquiry stage is a basic step that prevents downstream confusion.
Project fit and custom scope
For buyers requesting custom fill amounts, private label packaging, or non-standard configurations, WUMO reviews the full project scope — fill amount, vial format, label requirements, destination, and timeline — before committing to a formal quotation. Custom projects that are not scoped in advance consistently encounter MOQ, lead time, or documentation issues that delay final ordering.
How Does WUMO Support Qualified Epitalon / Epithalon B2B Sourcing Projects?
WUMO supports qualified B2B buyers with Epitalon / Epithalon sourcing discussion, specification review, documentation review, and project quotation. The process is structured for buyers preparing formal RFQs — not for retail or consumer purchasing.
WUMO can assist qualified buyers in clarifying:
- Bulk powder or lyophilized vial format selection based on project type
- Product identity, naming consistency, and AEDG sequence reference confirmation
- Documentation scope: COA, HPLC, LC-MS, SDS, and specification sheet
- MOQ and volume tier discussion based on format and project scale
- Lead time expectations for stock vs production vs custom fill scenarios
- Quote unit basis: USD/g, USD/vial, or USD/box
- Custom fill feasibility: fill amount, vial configuration, batch minimum
- Neutral label or private label packaging discussion
- Storage condition and shipment planning considerations
- Project fit review before formal quotation is issued
WUMO’s sourcing support is suitable for overseas peptide distributors, private label brand owners, OEM project teams, formulation consultants, and compounding-related procurement teams evaluating Epitalon / Epithalon as a B2B sourcing project.
To discuss an Epitalon / Epithalon sourcing project, contact WUMO.
Frequently Asked Questions
What is the CAS number for Epitalon / Epithalon and how do I confirm it with a supplier?
The CAS number commonly referenced for Epitalon / Epithalon is 307297-39-8. To confirm it with a supplier, request the product’s specification sheet and verify that the CAS number appears consistently across the specification sheet, COA, and LC-MS data. A supplier that cannot produce a specification sheet with a confirmed CAS reference at the inquiry stage has not completed the documentation preparation required for structured B2B procurement. Naming variation between documents is a qualification gap, not just an administrative detail.
What sequence should buyers confirm when sourcing Epitalon / Epithalon?
The sequence commonly referenced for Epitalon / Epithalon is Ala-Glu-Asp-Gly — a tetrapeptide also identified by the shorthand AEDG. Buyers should request that this sequence be listed explicitly in the supplier’s specification sheet. When issuing an RFQ, stating both the preferred product name and the AEDG sequence reference ensures the supplier quotes against the correct specification, regardless of which spelling they use internally.
Is Epitalon the same as Epithalon in a sourcing context?
In most B2B sourcing contexts, Epitalon and Epithalon refer to the same tetrapeptide — Ala-Glu-Asp-Gly, CAS 307297-39-8. The two spellings are regional and catalog variants rather than distinct chemical entities. However, buyers should not assume equivalence without confirming that both spellings in a supplier’s documentation point to the same sequence and CAS reference. A supplier that uses both spellings inconsistently across a single document set has a naming traceability gap that should be resolved before quotation.
What documentation should I request before issuing an RFQ for Epitalon?
Request five documents at the qualification stage: COA (batch-specific, with lot number), HPLC report (with chromatogram and method details), LC-MS report where available, SDS, and the supplier’s specification sheet. For a tetrapeptide like Epitalon / Epithalon, LC-MS is straightforward to supply and should be available from any supplier operating at a B2B documentation standard. Review all five documents before comparing quotes — a missing document often signals an incomplete sourcing package.
Why is LC-MS useful for Epitalon / Epithalon supplier qualification?
LC-MS confirms the observed molecular weight of the peptide, providing an independent identity check beyond the HPLC purity figure. For Epitalon / Epithalon — a short, four-residue sequence — LC-MS data should be readily available from a qualified supplier. If a supplier cannot supply LC-MS for a tetrapeptide, buyers should ask for an explanation before proceeding. The absence of LC-MS data on a short sequence is unusual and warrants clarification during the qualification stage.
What is the difference between bulk powder and lyophilized vial format for Epitalon / Epithalon?
Bulk powder is quoted in USD/g and suits buyers who need downstream processing flexibility, reformulation, or repackaging. Lyophilized vials are quoted in USD/vial or USD/box and are more appropriate for distribution-ready, private label, or OEM projects. The two formats involve different MOQ structures, lead times, documentation scopes, and specification requirements. Comparing them directly without separating these dimensions produces unreliable cost comparisons.
How should I compare USD/g and USD/vial quotes for Epitalon / Epithalon?
To compare USD/g and USD/vial quotes meaningfully, buyers need to know the fill amount per vial (mg/vial), the vial count per box, the net peptide content per unit, and whether filling, packaging, and labeling costs are included in the unit price. A USD/vial quote without a stated fill amount cannot be normalized or compared against any other quote. Buyers should request these details from every supplier before attempting a cost comparison. See also Peptide Quote Units: USD/g vs Vial vs Box.
What fill amount should I specify for Epitalon / Epithalon lyophilized vial sourcing?
The appropriate fill amount per vial depends on the buyer’s intended product configuration and downstream distribution format. When issuing an RFQ for lyophilized vials, buyers should specify their target fill amount in mg per vial explicitly. The supplier can then confirm feasibility, advise on the appropriate vial size, and calculate accurate fill weight based on the confirmed salt form. Leaving fill amount unstated in the RFQ typically results in a quote that cannot be used for project planning or cost comparison.
What is a realistic MOQ for Epitalon / Epithalon sourcing projects?
MOQ for Epitalon / Epithalon depends on format, stock availability, and whether the project involves custom fill or private label packaging. Bulk powder MOQ is typically defined by batch weight or available stock quantity. Lyophilized vial MOQ is typically defined by the minimum fill batch, which is set by fill equipment capacity. Custom configurations carry higher MOQ. Buyers should request written MOQ confirmation that specifies whether the figure refers to a stock order, a production batch, or a fill batch minimum — the three scenarios have different planning implications.
What are the most common red flags when evaluating Epitalon / Epithalon suppliers?
The most common red flags are: inconsistent naming across documents, sequence not listed in the specification sheet, COA without a batch number, purity figure stated without an HPLC chromatogram, LC-MS unavailable for a tetrapeptide without explanation, USD/vial quote without a fill amount, MOQ stated verbally with no written confirmation, lead time given as a single number without scope, and documentation offered only after payment. Buyers should treat each gap as a question and evaluate the quality of the supplier’s response before proceeding.
What should a stronger Epitalon / Epithalon RFQ include?
A stronger RFQ should state: preferred product name (Epitalon, Epithalon, or AEDG), sequence reference, CAS number, requested format (bulk powder or lyophilized vial), fill amount if vials are needed, purity threshold and preferred test method, required documentation package (COA, HPLC, LC-MS, SDS, specification sheet), target MOQ and acceptable range, destination country or region, project timeline, and preferred quote unit. Supplying these fields prevents suppliers from quoting against their own defaults and makes quote comparison actionable.
Does COA and HPLC documentation guarantee import clearance for Epitalon / Epithalon?
No. COA and HPLC documentation confirm product specification at the point of testing. They do not guarantee import clearance, regulatory approval, or end-use authorization in any jurisdiction. Import eligibility depends on the regulatory requirements of the destination market, the buyer’s applicable licenses or registrations, and the classification of the product under local rules. Buyers are responsible for evaluating the regulatory requirements applicable to their sourcing project independently of the documentation review process.
How does WUMO review Epitalon / Epithalon sourcing projects before issuing a quotation?
WUMO reviews five areas before issuing a formal Epitalon / Epithalon quotation: product identity and naming alignment (sequence, CAS, naming consistency), documentation availability (COA, HPLC, LC-MS, SDS, specification sheet), MOQ and quantity feasibility for the requested format, quote unit basis alignment (USD/g vs USD/vial vs USD/box), and project fit including custom fill scope if applicable. No auto-generated quotes are issued for specification-sensitive projects. Buyers with a defined RFQ are welcome to submit a project inquiry.
If you are evaluating Epitalon / Epithalon as a B2B sourcing project, WUMO can review your specification, confirm available documentation, and discuss format options, MOQ, and project fit before issuing a formal quotation. Qualified B2B buyers are welcome to submit a project inquiry with product definition, preferred format, target quantity, quote unit, and documentation requirements. Contact WUMO to start a project discussion.